$AFFX (Affymetrix Inc.)

$AFFX {{ '2016-03-23T16:26:16+0000' | timeago}} • Announcement

$AFFX said the Special Meeting scheduled for March 24, to consider approval of the merger agreement with $TMO and related matters, will be convened and immediately adjourned without vote on any proposal and will reconvene on March 31. $AFFX's stockholders of record on Feb. 18, are entitled to notice of, and to vote at, the special meeting.

$WOR {{ '2017-07-25T20:52:54+0000' | timeago}} • Infographic

$WOR has priced its $200MM aggregate principal amount of senior notes due 2032. The notes bearing 4.3% interest are sold to the public at 99.901% of the principal amount. Worthington will use the proceeds from the offering mainly to repay loan and the amounts outstanding under its revolving trade accounts receivable securitization facility.

$ABT {{ '2017-07-25T15:58:08+0000' | timeago}} • Announcement

$ABT has announced that the first patient has been enrolled in a clinical study evaluating the short-term use of common blood thinning medicines, called dual antiplatelet therapy (DAPT), after receiving a Xience everolimus-eluting coronary stent to unblock coronary arteries. Approx 2,000 patients at 100 sites in the US and Asia will be studied.

$WOR {{ '2017-07-25T15:08:35+0000' | timeago}} • Infographic

$WOR has decided to offer $200MM aggregate principal amount of senior notes due 2032. Worthington intends to use the net proceeds from the offering to repay outstanding borrowings and to repay amounts outstanding under its revolving trade accounts receivable securitization facility.  The remaining amount will be added to working capital.

$BIIB {{ '2017-07-25T14:47:25+0000' | timeago}} • Announcement

$BIIB, which competes with $ABT and $PFE, posted record 2Q17 revenue, on strong Spinraza demand in the US, though YoY profit fell 18% on higher expenses. Net earnings attributable to Biogen plunged to $862.8MM, while diluted EPS fell 15.03% to $4.07. Revenue, however, jumped 6% to $3.1Bil. $BIIB lifted its outlook due to strong Spinraza sales.

$XYL {{ '2017-07-25T13:41:35+0000' | timeago}} • Announcement

$XYL secured a contract to supply its advanced Wedeco LBX Series UV disinfection system to heighten protection against cryptosporidium at the City of West Palm Beach Water Treatment Plant, the first plant in Florida to add UV disinfection.

$PKI {{ '2017-07-24T21:21:06+0000' | timeago}} • Announcement

$PKI BoD declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2017. This dividend is payable on Nov. 10, 2017 to all shareholders of record at the close of business on Oct. 20, 2017.

$GE {{ '2017-07-21T18:59:39+0000' | timeago}} • Webcast

John Flannery, who is to be $GE's 13th CEO effective Aug 1, 2017, brushed aside concerns that the company might find itself in a state of limbo during the transition period. He said there is no operational paralysis within the team, adding robust discussions will happen in November regarding the future of course of $GE's operations.

$GE {{ '2017-07-21T18:13:06+0000' | timeago}} • Webcast

$GE reiterated its FY17 net earnings guidance of $1.60-1.70 per share on organic sales growth, which is expected in the range of 3-5%. The company added that EPS is trending to the bottom end of the projected range, as Oil and Gas continues to witness weakness.

$GE {{ '2017-07-21T17:28:46+0000' | timeago}} • Webcast

Cash flow from operations, one of $GE's closely watched financial metric, plummeted 67% to $3.6Bil in 2Q17. The Boston, Massachusetts-based conglomerate said this was primarily due to the sale of its appliances division.

$GE {{ '2017-07-21T12:51:53+0000' | timeago}} • Infographic

$GE General Electric Earnings AlphaGraphics: Q2 2017 highlights

$GE {{ '2017-07-21T11:43:55+0000' | timeago}} • Announcement

$GE CEO Jeff Immelt said, "We expect cash flow to continue to improve throughout the year. We’ve reduced our industrial structural costs year-to-date by $670MM and we are on track to meet or exceed our $1Bil cost reduction target for the year."

$GE {{ '2017-07-21T11:40:52+0000' | timeago}} • Announcement

Primarily due to $GE's shift of focus into industrial operations, its backlog in 2Q17 grew 2% to $327Bil, while orders increased 6% to $28.3Bil. $GE has a history of orders and backlogs growing faster than its revenue.

$GE {{ '2017-07-21T11:38:01+0000' | timeago}} • Announcement

$GE's total revenue in 2Q17 fell 12% to $29.6Bil due to weakness in its Energy Connections segment, which supplies automation products to various industries including marine, mining and oil & gas. Revenue from this segment fell 27% during the quarter.

$GE {{ '2017-07-21T11:35:13+0000' | timeago}} • Announcement

In 2Q17, which marks the end of Jeff Immelt at the helm of $GE after 16 years, the multinational conglomerate posted net earnings that more-than-halved to $1.19Bil, or $0.13 per share. On a non-GAAP basis, EPS declined 45% to $0.28 during the quarter.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$NEM {{ '2017-07-19T20:55:03+0000' | timeago}} • Announcement

$NEM elected Sheri Hickok and Molly Zhang to its BoD. Hickok is currently General Manager, Global Product Development, Onshore Wind at $GE's Renewable Energy. Zhang currently serves as a director of Cooper Standard Automotive and XG Science as a supervisory board member at GEA Group in Germany.

Recent Transcripts

WAT (Waters Corporation)
Tuesday, July 25 2017 - 12:00pm
GE (General Electric Company)
Friday, July 21 2017 - 12:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
WOR (Worthington Industries, Inc.)
Thursday, June 29 2017 - 2:30pm
UQM (UQM Technologies Inc.)
Thursday, May 11 2017 - 8:30pm
HOLX (Hologic Inc.)
Wednesday, May 10 2017 - 8:30pm
CVU (CPI Aerostructures Inc.)
Tuesday, May 9 2017 - 12:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
PKI (PerkinElmer Inc.)
Thursday, May 4 2017 - 9:00pm
FLDM (Fluidigm Corporation)
Thursday, May 4 2017 - 9:00pm
PSDV (pSivida Corp.)
Thursday, May 4 2017 - 8:30pm
CBMX (CombiMatrix Corporation)
Thursday, May 4 2017 - 8:30pm
BDX (Becton, Dickinson and Company)
Thursday, May 4 2017 - 12:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
QGEN (Qiagen NV)
Wednesday, May 3 2017 - 1:00pm
LBY (Libbey Inc.)
Tuesday, May 2 2017 - 3:00pm
XYL (Xylem Inc.)
Tuesday, May 2 2017 - 1:00pm
TECH (Bio-Techne Corp.)
Tuesday, May 2 2017 - 1:00pm
BDX (Becton, Dickinson and Company)
Tuesday, May 2 2017 - 12:00pm
STS (Supreme Industries Inc.)
Monday, May 1 2017 - 1:00pm

AlphaGraphics you may like